Has the US Behemoth Become Too Big to Fail? Jacobs behind £200bn of UK Infrastructure Projects

The US engineering behemoth ‘Jacobs’ has long been dominating majority of London’s infrastructure including £500 million-worth of projects related to the High Speed Two rail line, £5 billion super-sewer project, restoration project of Palace of Westminster worth over £4 billion, and many more.

In short, Jacobs is the biggest company people in London have never heard of.

According to research by the Standard, the company is reportedly working on massive UK infrastructure projects worth nearly £200 billion. Jacobs’ dominance has raised several concerns that it has become too big to fail or too strong when it comes to offering public work. Its huge size, owing to working as both contractor and project manager, has also led to perceptions of conflict risks.

In 2017, the US behemoth acquired its awkwardly-named US rival CH2M in a £2.5 billion deal, giving a big push to Jacobs’ overbearing presence. In addition, the deal created an engineering giant with 10,000 workforce in the UK alone, and 80,000 worldwide.

Both the companies were already serious heavyweights in the UK. CH2M came to prominence when it was assigned to be project manager of the London 2012 Olympics, alongside Mace and Laing O’Rourke.

Jacobs’ dominance, on the other hand, surged more stealthily through a long chain of acquisitions of which CH2M is the latest.

Potential conflict of interest has been raised long before the merger which led to CH2M’s withdrawal from Phase 2 contract of the HS2 line, although it was named development partner of the project on Phase 1 in 2012.

Despite the termination, Jacobs still holds the Phase 1 contract, assigned to CH2M, to manage and evaluate all the professional services firms operating on Phase 2. Most interestingly, most of those projects have gone to Jacobs’ other divisions.

In 2016, Jacobs was named design partner on the first phase of HS2; in the following year, on second phase of the route, the company achieved the role of Environmental Overview Consultants.

Jacobs’ spokesperson said that the firm is one of the premier professional services consultants supporting major infrastructure projects in the UK and taking into account the degree of talent, it has been awarded several high-profile contracts. This along with consolidations in the industry can give rise to risk of conflicts of interest, the spokesperson added.

Moreover, many in the industry complain about the company’s influence over officials in public sector.

Jacobs have claimed that they remain dedicated to ensuring integrity in the delivery of key public programs to the customers’ satisfaction.

Evening Standard (ES) reported that the company’s access to the British public’s money makes its shares a honeypot for investors.

Jacobs’ chairman and chief executive Steve Demetriou highlighted the company’s business strength in the UK. Last year, it raised $3.3 billion through a sale of one division and is on the lookout for more acquisitions. Jacob’s plans for domination is not over yet, ES reported.

IMF Warns No-deal Brexit and Trade Tensions Could Hit Global Economy Growth

In a new report on world economic outlook, the International Monetary Fund (IMF) has warned that escalation of Trump’s trade war with China and a no-deal Brexit could undermine global economic growth.

The IMF is now predicting the world economy to grow 3.5% in 2019, though it forecast the growth of 3.7% in October last year. As reported in BBC news, the global figure projects weaker growth than a year earlier.

For the UK, the report estimates the GDP to grow by 1.5% this year and 1.6% in 2020, however, it said that there is considerable uncertainty around that figure.

Tariff increases enacted by the US President in the nation and its counterpart in China have already been a major factor of the previous economic slowdown.

For China, the IMF expects the slowdown to continue, while growing by 6.2% this year and next.

The new assessment also includes revisions for the developed economies, particularly the European nations.

Unexpected developments have inflicted the economic damage, the report said, which in Germany followed the introduction of new fuel emissions standards, leading to disruptions to the motor industry in terms of sales and production.

In Italy, concerns are raised as the financial markets have been unstable by the government plans to expand spending, while economy slumped amid the battle with EU officials over the budget this year. According to the report, there are continued weaknesses in Italy’s banking system as well.

The UK’s economic outlook is particularly uncertain, the report said. The 2019 figure is unchanged but there appears to be small upward revision to the forecast for 2020. Earlier, the IMF had also warned that no-deal Brexit would involve significant costs to the Britain’s economy.

Rising trade tensions could spark a further deterioration to the global economy growth this year which have also been a recurrent topic in the latest IMF assessments. According to the organization, the main priority of shared policy is for nations to resolve quickly and co-operatively their trade disagreements and resulting policy uncertainty, instead of raising destructive barriers further and destabilizing an already plummeting world economy. It had already witness a downgrade in the October forecast due to impact of the tariff increases imposed by the US and China, the report added.

The IMF said that there are also risks from financial markets. Moreover, trade tensions and financial markets have intertwined in the most recent times which tightened the financial conditions, while increasing the risks to global growth.

Primark Exceeds Expectations in Retail Profits in the Christmas Season as Other Fashion Retail Chains Suffer Ongoing Gloom

Dublin-based fashion retail chain Primark has reported a rise in market share as profits increased during the Christmas season sales in its retail stores across UK. The fashion chain which only sells its products at the high street retail stores has never launched its products on its website although they are available on other ecommerce platforms including Amazon and eBay.

One third of all products sold online are returned implying that Primark’s modest product prices won’t be able to cover the shipping costs, according to the John Bason, finance chief of Associated British Foods, Primark’s parent company. Accordingly Primark has adopted a strategy of staying away from online sale of products and rather focused on expanding offline retail presence. The chain recently announced new store launches in Eastern Europe such as Slovenia and Poland as the sales in Eurozone increased by over 5% for 16 weeks leading up to 5 January 2019.

In terms of volume of sales the company is already Britain’s biggest fashion retail chain, while in terms of value its ranked third after Marks and Spencer who retains the top spot. Primark’s good performance over the Christmas season is an aberration in the industry as many retail chains announced store closures owing to increasingly shifting consumer preference from retail to online shopping. Marks and Spencer was recently in news for closure of 17 retail stores.

Mr. Bason said that although rivals stepped up expenditure on promotions, the firm could turn up profits owing to the several fashion hits this season such as faux sheepskin jackets and animal printed dresses despite a reduction in discounting. Other contributing factors were tighter stock control and lower prices. Primark exceeded its performance expectations after a December update which threatened challenging trading conditions. Its shares rose by over 6% after the announcement.

ABF, the parent company with huge presence in food business warned of losses in its bakery business which owns Sunblest, Allinson and Kingsmill brands. The company which has launched nine stores in USA and planning two more has reported a strong sale in the country along with Spain, another high performer. As worldwide sales in established stores fell by 2% over the period of four months, the strengthening of pound against dollar, which is primary mode of payment to eastern countries, prompted a rise in profit margins.

Mr. Bason said that although customers love the comfort of online shopping, they can offer the lower price range because they don’t have to bear the cost of home delivery. He added that Primark’s strength lies in the fact that its stores are a place where people come to have fun and don’t leave without buying something.

Google Threatens the Withdrawal of News Service from Europe if the New EU Rules are Finalized

The European Union is working towards the finalization of a new copyright law which has alarmed search giants including Microsoft and Google. The new copyright law seeks to give publishers the right to demand compensation from Google-parent Alphabet Inc. and other online platforms including Facebook if small snippets of news from their articles appear on their search results. Google is considering to wind up its news service from the Europe completely if the controversial law gets passed.

Google’s public policy manager for Europe region, Jennifer Bernal said that the company is contemplating the prospect of complete wind-up of its news service in Europe as a response to the new law. She added that the Google would consider all possible options before making any final decision but any withdrawal would be reluctant decision.

Two proposed rules have attracted the most controversy, one Article 11 of the law may force Google, Microsoft and others to pay publishers if small snippets appear on its search results and another Article 13 requires online platforms like Instagram and Youtube to verify copyrights before letting users upload it on their site. When Germany and Spain first implemented Article 11 like rule, the news publishing websites reported a plunge in website traffic from the search engines.

The European Commission first proposed these rules in 2016 but due to the disagreement among various member states about the scope of the law it has postponed the implementation of the rules. The EU had plans to finalize the rules by the first week but resistance among member states may drag the legislation process longer.

Google claims that it doesn’t make any money from its news aggregation service and that a harsh withdrawal would not lead to any financial consequence to the company. However, news results from publishers entice the mobile users to come back to the search panel leading to more searches which generates lucrative ad revenues for the company. Google’s withdrawal would also mean losing grounds to other competitors in the news aggregation service field which includes Apple and Microsoft.

Although there are numerous issues surrounding the legislation, but one important issue includes the concerns small print publishers. The first draft of the rules included a provision which enabled some publishers to waive their rights to the news content appearing on the search engine. This meant that larger news organizations with deep pockets would allow their content to appear freely on the search engine in exchange for increased web traffic to their sites. This would prove a disadvantage for small publishers. But European parliament introduced a provision taking into consideration the concerns of the small print publishers which disallows any publishers from allowing their content on Google freely.

Some activists and small publishers are blaming Google’s intense lobbying efforts for the delay in legislative process to finalize the rules. The law has pitted the search giant against small publishers and activists. Although Google has threatened withdrawal, Mr. Francois Godard, a European Media analyst said that he doesn’t buy the threat saying that Europe being the key market for Google, ‘’they cant afford to lose it’’.

Experimental Drug Promises a New Option for Type 2 Diabetes

An experimental drug may help curb blood sugar of patients with type2 diabetes without causing it to drop to extremely low levels.

In a new study, a team of researchers has discovered that the compound–dubbed TTP399–improved the blood sugar control of patients, when it was added to metformin, the first-line medication for type 2 diabetes, for 6 months.

Most interestingly, it helped control the blood sugar without causing hypoglycemia in which blood sugar decreases, if severe, can lead to loss of consciousness or convulsions.

Findings of the research are detailed in a paper featured in the journal Science Translational Medicine.

The study extends a previous ‘phase 2’ trial and more research is required before the compound can be added to existing medication of type 2 diabetes, according to senior researcher Carmen Valcarce, chief scientific officer at vTv Therapeutics which is based in North Carolina and develops TTP399.

However, she said that the effects observed so far on patient’s blood sugar control are comparable to or even more improved than the effects of existing medications for the disease.

As reported by American Diabetes Association, type 2 diabetes has affected more than 30 million people in the United States in 2015. It occurs when the body can longer utilize insulin, a hormone responsible for regulating sugar or glucose level in the blood. When the level of blood sugar habitually increases, over time, it can take a toll on the body, causing damage to nerves, blood vessels, heart, eyes, and kidneys.

Although there are various medications for the disease, there is still a need for additional and more effective options, Valcarce said.

TTP399 typically activates an enzyme called glucokinase which acts as a sensor for blood sugar. Other compounds developed to target this enzyme have been stymied by side effects including hypoglycemia and increases in blood fat called triglycerides.

Some of these compounds affected glucokinase in liver as well as pancreas and activation of the enzyme in the pancreas may have caused the blood sugar to drop, Valcarce said. So, TTP399 was designed to prevent such problems.

The researchers tested the compound in 190 study participants who had type 2 diabetes. All were under the medication of metformin; the researchers randomly assigned some patients to add a dose of TTP399 daily, while the rest added either sitagliptin (a diabetes drug) or inactive placebo pills.

After 6 months, patients who added the new compound showed a greater reduction in their A1C level compared to ones who took placebo pills. Researchers found no cases of extreme blood sugar drops or any negative effects on triglycerides.

Longer-term research are still required to determine the effectiveness and safety of the new drug.

Generation of Children May Live Shorter Lives than Their Parents due to Obesity

A generation of kids will possibly live shorter lives compared to their parents if nothing is done to cope with Wales’ obesity crisis, according to Dr. Frank Atherton, a chief medical officer.

He predicted that obesity will soon takeover smoking as the biggest risk to public health and in 25 years’ time, it can become one of the main causes of cancer in women.

Current Scale of Obesity Problem in Wales

Nearly 60% of population aged 16 and above are either obese or overweight, while 60,000 adults of the same age range are severely obese and are at high risk of health complications.

Over 27% of children aged 4-5 who are starting primary school are obese or overweight and each year, nearly 10,000 more adults are becoming obese.

According to the latest figures, obesity problem in Wales is getting worse than any other regions of the UK which has help responsible for a plethora of various factors such as lower rates of exercise, deprivation, and increasing availability of cheap convenience food.

Some Major Causes of Obesity in Wales

  • Around 70% of adults do not consume five essential portions of fruit and vegetables each day.
  • On average, both children and adults eat the equivalent 10-12 cubes of sugar a day which is double the recommended amount.
  • More than 50% of adults fail to do the essential amount of physical activity each week.
  • 20% of boys aged between 11 and 16 does the least recommended level of exercise for 60 minutes each day. It stands at just 1 in 10 for girls the same age.
  • Around 50% of primary school children go to school by car.

With rising need to reverse the existing trends, the Welsh government will launch ‘Health Weight: Healthy Wales’, the country’s first-ever obesity strategy, later this year.

The consultation document’s proposals detailed out ‘action points’ where changes are required to be made to facilitate and guide behavioral change among the Welsh public.

Some Important Points in the Consultation Document

  1. Creating an improved healthy environment: This aims to allow people to make healthier food choices and be more active each day.
  2. Making more healthy settings: This focuses on ensuring that schools, offices and even leisure facilities are contributing to improvement of people’s health and well-being.
  3. Motivating people to attain a healthy body weight: This includes influencing people to reach and maintain their body weight in a healthy manner.
  4. Enhancing leadership and enabling change: This emphasizes the importance of entire system approach to address obesity.

Report Reveals Outdated Commissioning Contracts are Failing UK Mental Health Services

A recent report, released by Johnson & Johnson’s Janssen Pharmaceutical Companies, uncovers that outdated contracts of mental health commissioning are failing cognitive health services in the UK.

UK mental health services are falling behind its physical health services as the healthcare providers are relying on outdated commissioning process, according to the report. It also revealed the challenges encountered by pressurized mental health units in the UK, with a particular focus on schizophrenia.

Mental health holds for 28 percent the demand on the National Health Service (NHS), but its total CCG budget is only 13 percent. The report has been published to correspond with the Mental Health: Parity of Esteem, an event by IPPR think tank.

Schizophrenia–a mental disorder that affects an individual’s ability to think, feel, and behave clearly–represents the second highest number of total admitted bed days for patient care, in comparison with other health diagnosis including both mental and physical. In 2016-17, the disorder reported 2.5 million bed days approximately.

Schizophrenia is considered among the most complex mental health disorder which is challenging to manage and brings a huge burden to the NHS. In 2012-13, schizophrenia along with psychosis cost the NHS an amount of £2 billion which is expected to increase with growing number of patients. Each year, people with the disorder have an average of 36.4 contacts with healthcare providers.

Analysis in the report indicated that mental health is continuously falling behind physical health, mostly due to how these services are funded and organized. Although new commissioning methods used in physical health have been introduced to enhance innovation and integration of care, findings revealed that most mental healthcare professionals are still relying on outdated commissioning practices.

These practices include block contracts, providing a set payment of service delivery over a time period. Report findings show that use of block contracts could lead to: shortage of beds, ward overcrowding, delayed appointments as well as discharges, lack of personalization and integration of care, and cherry picking patients.

The need to settle these issues has never been given much importance. Compared to 2010, about 1400 more people are accessing mental health services every day. Although UK’s NHS Mental Health Dashboard manages achievement in providing services for mental health, there is no transparency about where the money is spent or whether it is truly leading to better outcomes. Poor accountability suggests that there is less incentive for commissioners to modify the practices.

According to the report, if significant modifications are not brought to improve accountability within the commissioning system, there will be little or no development in efficient services for people suffering from schizophrenia and other mental disorders.

Early Adult GCA Strongly Predicts Mental Capacity Later in Life, Finds a Study

Youthful general cognitive ability (GCA), a multiple set of skills involved in perception, memory, and thinking which includes reasoning, is a ‘strong predictor of cognitive function’ and reserve later in life compared to other factors including higher education, complex occupations, and participating in late-life intellectual activities, according to a recent study.

Higher education and late-life intellectual pursuit like socializing, reading, or solving puzzles are linked with improved cognitive reserve and lower risk of dementia. Cognitive reserve is the ability of the brain to improvise or find alternate ways to complete a task, and may even help people adjust with changes related to aging.

In the new study, a team of researchers at the University of California San Diego sought to address the confusion posed by these associations; whether being in highly complex occupation help maintain cognitive abilities or individuals with higher cognitive ability are likely to be in more complex jobs.

The team examined over 1,000 men taking part in the Vietnam Era Twin Study of aging. All were veterans, of which around 80% have reported no combat experience. In addition, all the participants, now aged between 50 and 60 years, took the Armed Forces Qualification Test in their 20s which is a measure GCA.

As part of the new study, the research team assessed performance of participants who are in their mid-60s using the same GCA measure, including assessments in seven different cognitive domains such as verbal fluency, abstract reasoning, and memory.

The researchers found that participants’ GCA at age 20 accounted for 40% of the variance in the same measure at age 62, and nearly 10% of the variance in each cognitive domain. After the GCA analysis, they concluded that other factors had no or very small effect; lifetime education, job complexity, and participating in intellectual activities accounted for even less than 1% of variance at age 62.

Findings of the study, published in the journal PNAS, suggest that the impact of other factors than GCA on cognitive function later in life likely reflects reverse causations. According to first author William S. Kremen, they are widely downstream effects of youthful intellectual capacity.

Further, the researchers discovered that age 20 GCA, but not higher education, was associated with the surface area of the cerebral cortex at the age 62. This part of the brain is responsible for thinking, understanding language, perceiving, and producing.

Additional investigations are needed to confirm the finding, the researchers said.

New Report by EAT-Lancet Commission Suggests a Planetary Health Diet with 50% Reduced Intake of Sugar and Red Meat

The Lancet, one of the most prestigious medical journals in the world, has released a report which prescribes an ideal and healthy diet. The new dietary plan has taken into consideration all the factors of human body as well as meeting UN Conference on Climate Change goals for reducing carbon emissions.

The report has recommended a reduction in consumption of red meat and sugar by almost 50% along with increasing the intake of nuts, vegetables and fruits. The diet is healthy and environment-friendly causing minimum damage to the planet intended for a worldwide adoption.

The report was submitted by EAT-Lancet Commission, a non-profit and independent organization, which involved 18 co-authors, 19 scientists from 16 countries. The group was tasked with providing global scientific targets for sustainable food production and healthy diet.

The commission proposed recommendations for an average man with the average dietary calorie requirement of 2500 calories. Out of the 2500 calories, 800 calories must come from whole grain i.e. corn, wheat and rice, while 204 calories from vegetables and fruits, and fewer than 30 calories from meat (pork, lamb, beef). Additionally, it suggested an avoidance of added fat and added sugar. The report stated that the proposed diet will abate the approximately 11 million premature deaths per year worldwide as unhealthy diet is one of the leading cause of health issues.

The ideal planetary health diet is aimed at achieving the UNFCCC Paris targets to ensure sustainable food production practices. At the same time, the report has recommended to take cultural sensitivities in consideration. The planet will host 10 billion people by the end of 2050 which will put enormous strain on natural resources by the overgrowth in population. This will inevitably urge us to look for healthy alternatives for unsustainable dietary hobbits.  

One of the members of the commission, a professor at Harvard, Walter Willett said that the diet of people across the globe needs to change. While the environmentally conscious diet allows two fish servings and a beef burger per week it specifies that most of the protein must come from non-meat sources. While one third of each food plate of the diet is sourced from wholegrain more than half of it comes from vegetarian sources.

Marco Springman, a commission member from Oxford University, said that the report is based on sound scientific and epidemiological evidence as researchers studied huge data about dietary needs of cohorts of people. The Lancet is one of the most reputed and prestigious medical journals in the world with an experience which exceeds a century as its first issue was published in the year 1823.  

Lilly Gains Approval from NICE for its Verzenio Drug Which Acts as a CDK4/6 Inhibitor

Eli Lilly, an Indianapolis-based global pharmaceutical company has gained approval for its Verzenio drug used for treating breast cancer patients from UK’s National Institute of Health and Care Excellence (NICE). The approval has set stage for a 3 way competition in the CDK4/6 inhibitor drugs segment. The new drug is another addition to other such drugs including Pfizer’s Ibrance and Novartis’s Kisqali.

NICE has recommended in its draft guidance the use of the drug for treating human epidermal growth factor-2 (HER2) negative, hormone receptor positive and metastatic breast cancer as part of initial hormone therapy. NICE said that the drug is cost-effective compared to other CDK4/6 inhibitor class drugs after Lilly revised its price offering by a revised patient access scheme.

Ibrance was the first drug launched which showed blockbuster performance earning close to $4 billion in 2018 worldwide, Kisqali is far behind with expected sales to reach $1.6 billion in 2022. The Verzenio drugs approval will give competition to the Kisqali for the second position in the market. Although Verzenio is far behind Kisqali and Ibrance as they gained their approval in November 2017, but analysts say that the Verzenio will fare better than others as it requires patient to follow a continuous dosing regimen without going on treatment holidays to avoid toxicity such as neutropenia. The UK listed price of Verzenio is same as its rivals costing around £2,950, but NICE made sure that the company gives discounting offers.

Around 40,000 women across UK are diagnosed with breast cancer every year, while 8000 out of them will be eligible to receive treatment by the Verzenio drug. The drug is being appraised by NICE along with fulvestrant. Delyth Morgan, Breast Cancer Now’s chief executive said that the NICE approval will help in improving choices available to breast cancer diagnosed women, giving them greater control over their life.

Lilly’s drug Abemaciclib (Verzenio), which in 2015 was designated as breakthrough therapy for breast cancer by the USFDA, can be used as a replacement for robociclib and palbociclib. The drug which acts as a CDK4 and CDK6 inhibitor can come with some side effects. It is essential that the patients are informed about the benefits and possible side effects of the therapy they are receiving. She further added that they look forward to the use of the drug as part of National Health Service and giving Verzenio in combination with fulvestrant could significantly improve patient’s response to treatment who have already received hormone therapy.